Shares of McKesson Corporation (NYSE:MCK – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the seventeen analysts that are covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation and fourteen have issued a buy recommendation on the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $962.6667.
MCK has been the topic of several analyst reports. Bank of America decreased their price target on shares of McKesson from $1,040.00 to $1,000.00 and set a “buy” rating on the stock in a research note on Monday, April 6th. Wall Street Zen lowered shares of McKesson from a “buy” rating to a “hold” rating in a research report on Saturday, June 27th. Wells Fargo & Company reduced their price objective on shares of McKesson from $925.00 to $812.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 12th. William Blair initiated coverage on shares of McKesson in a research report on Tuesday, April 28th. They set an “outperform” rating on the stock. Finally, Citigroup lifted their target price on shares of McKesson from $945.00 to $1,000.00 and gave the stock a “buy” rating in a research note on Friday.
Get Our Latest Stock Report on McKesson
Insiders Place Their Bets
Institutional Trading of McKesson
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. University of Texas Texas AM Investment Management Co. purchased a new stake in McKesson in the fourth quarter valued at approximately $25,000. Swiss RE Ltd. acquired a new position in McKesson during the fourth quarter worth approximately $26,000. State of Wyoming purchased a new position in McKesson during the second quarter worth approximately $29,000. Kingdom Financial Group LLC. purchased a new position in McKesson during the fourth quarter worth approximately $33,000. Finally, Birchwood Financial Partners Inc. acquired a new position in shares of McKesson in the 4th quarter valued at $33,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.
McKesson Stock Up 1.2%
Shares of NYSE:MCK opened at $850.94 on Friday. McKesson has a 52-week low of $637.00 and a 52-week high of $999.00. The stock’s fifty day simple moving average is $781.55 and its 200-day simple moving average is $838.73. The company has a market capitalization of $99.63 billion, a P/E ratio of 22.12, a P/E/G ratio of 1.38 and a beta of 0.31.
McKesson (NYSE:MCK – Get Free Report) last posted its quarterly earnings data on Thursday, May 7th. The company reported $11.69 EPS for the quarter, beating analysts’ consensus estimates of $11.56 by $0.13. McKesson had a negative return on equity of 345.35% and a net margin of 1.18%.The business had revenue of $96.30 billion for the quarter, compared to analyst estimates of $101.35 billion. During the same quarter last year, the company earned $10.12 earnings per share. The business’s revenue for the quarter was up 6.0% compared to the same quarter last year. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. On average, sell-side analysts anticipate that McKesson will post 44.28 earnings per share for the current year.
McKesson Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Tuesday, September 1st will be issued a dividend of $0.94 per share. This represents a $3.76 annualized dividend and a dividend yield of 0.4%. This is a positive change from McKesson’s previous quarterly dividend of $0.82. The ex-dividend date is Tuesday, September 1st. McKesson’s payout ratio is 9.77%.
About McKesson
McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.
The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.
Featured Stories
- Five stocks we like better than McKesson
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
